Filing Flows › Bodhi Tree Biotechnology (BDTB) › Q2 FY26
Bodhi Tree Biotechnology (BDTB) Q2 FY26 earnings results (second quarter fiscal 2026)
10-Q filed May 14, 2026
Bodhi Tree Biotechnology (BDTB) reported revenue of $15K for the second quarter fiscal 2026 (Q2 FY26). Operating margin was -186.2%, net loss $29K (194.6% of revenue).
Bodhi Tree Biotechnology, Q2 FY26: revenue $15K, operating margin -186.2%, net loss $29K, operating cash flow −$25K. The chart follows the revenue to costs, profit and cash.
| Q2 FY26 | Amount | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $15K | — | — |
| Operating profit | −$28K | — | — |
| Net earnings | −$29K | — | — |
| Operating cash flow | −$25K | — | — |
What changed
Revenue was $15K in Q2 FY26.
Operating costs exceeded revenue by $28K, an operating margin of -186.2%. The quarter ended with a net loss of $29K.
Operating cash flow was −$25K. Working capital and other items added $5K.
Questions
What was Bodhi Tree Biotechnology's revenue in the second quarter fiscal 2026?
Bodhi Tree Biotechnology (BDTB) reported revenue of $15K for the second quarter fiscal 2026 (Q2 FY26).
Was Bodhi Tree Biotechnology profitable in the second quarter fiscal 2026?
Operating loss was $28K (-186.2% of revenue) and net loss $29K.